Neuromuscular blockade in dystrophia myotonica with atracurium besylate.
The anaesthetic management of a young woman with dystrophia myotonica is described. The use of atracurium and monitoring of neuromuscular block allowed suxamethonium and neostigmine to be avoided, and thereby to reduce the risk of myotonic contractions. No adverse sequelae were observed.
D000328:Adult; D000768:Anesthesia, General; D001279:Atracurium; D004576:Electromyography; D005260:Female; D006801:Humans; D007546:Isoquinolines; D008991:Monitoring, Physiologic; D009223:Myotonic Dystrophy / Q000150:complications*; D009466:Neuromuscular Blocking Agents
D007546:Isoquinolines; D009466:Neuromuscular Blocking Agents; D001279:Atracurium